Literature DB >> 9479036

Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene.

J O Minta1, M Fung, S Turner, R Eren, L Zemach, M Rits, G Goldberger.   

Abstract

Complement factor I is a serine proteinase that regulates the classical and alternative pathways of complement by cleaving C3b and C4b and preventing the assembly of C3 and C5 convertase enzymes. In order to understand the regulation of factor I gene expression in liver cells, 4kb of the 5' flanking region of the gene was cloned, and the 1474-bp 3'-end was sequenced and shown to contain a number of transcription factor consensus sequences. A major and two minor transcription start sites were identified, respectively, at 152, 178, and 198bp upstream of the translation start site by primer extension analysis. The transcriptional activity of the 1474-bp fragment was analyzed by fusion of 5' deletion constructs to a cat-encoding gene expression vector and transient transfections into Hep G2 cells. A 273-bp fragment located at -112 to +161 relative to the major transcription start site was sufficient for promoter activity. The 3' fragment spanning +3 to +161 and containing a TATA-like element did not demonstrate promoter activity, suggesting that the core promoter resides in a 115-bp sequence located between -112 and +3. This region contains an Inr-like element overlapping the major cap site and a CTF-NF1 element, two potential CCAAT boxes and an AP-2 element partially overlapping an Sp-1 site. Thus, factor I promoter may belong to the TATA-less Inr-driven class II promoters whose transcription is regulated by Sp-1. The transcriptional activity of the 1474-bp 5' flanking fragment was upregulated by PMA, IL-6 and TNF-alpha, suggesting that factor I may be an acute phase reactant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479036     DOI: 10.1016/s0378-1119(97)00632-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.

Authors:  J Minta; M Fung
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 3.  The complement system: history, pathways, cascade and inhibitors.

Authors:  P N Nesargikar; B Spiller; R Chavez
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

4.  Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

Authors:  David M Cauvi; Gabrielle Cauvi; K Michael Pollard
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

5.  Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation.

Authors:  A M Chinnaiyan; M Huber-Lang; C Kumar-Sinha; T R Barrette; S Shankar-Sinha; V J Sarma; V A Padgaonkar; P A Ward
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 6.  The interaction between the complement system and hemostatic factors.

Authors:  Selin Oncul; Vahid Afshar-Kharghan
Journal:  Curr Opin Hematol       Date:  2020-09       Impact factor: 3.218

7.  Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-alpha and dexamethasone.

Authors:  Krishnaswamy G Tirumurugaan; Bit Na Kang; Reynold A Panettieri; Douglas N Foster; Timothy F Walseth; Mathur S Kannan
Journal:  Respir Res       Date:  2008-03-14

8.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation.

Authors:  S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.